Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526576 · ClinicalTrials.gov registry record · Phase 2
Adipose Derived Stem Cells in Facial Fat Grafting
A Phase 2 study, sponsored by Antria.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT02526576: Completed Phase 2 study, sponsored by Antria.
NCT02526576 is a Phase 2 study that has completed, run by Antria. The registered enrollment target is 34 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02526576, a Phase 2 study, has completed, sponsored by Antria.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
This phase two, randomized, double-blind study is designed to demonstrate the enhanced efficacy of SVF-enriched autologous facial fat grafts, in relation to standard, non-SVF enriched, facial fat grafts by evaluating volumetric retention and contour of the engrafted region over the course of one year.
Primary Outcome
To demonstrate that SVF administration, in concert with autologous facial fat grafts, is more efficacious, with regards to graft survival, than standard, non-SVF enhanced, autologous facial fat grafts
Interventions
- PROCEDURE Biopsy
- BIOLOGICAL Stromal Vasular Fraction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-07 |
| Phase | Phase 2 |
What the finished NCT02526576 record still lists
NCT02526576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 2 interventions - of which Biopsy is the first listed.
NCT02526576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02526576 about?
NCT02526576 is a clinical study titled "Adipose Derived Stem Cells in Facial Fat Grafting". This phase two, randomized, double-blind study is designed to demonstrate the enhanced efficacy of SVF-enriched autologous facial fat grafts, in relation to standard, non-SVF enriched, facial fat grafts by evaluating volumetric retention and contour of the engrafted region over the course of one yea...
What is the current status of trial NCT02526576?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2015-08. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02526576?
The interventions under investigation include: Biopsy (PROCEDURE), Stromal Vasular Fraction (BIOLOGICAL).
Who is sponsoring clinical trial NCT02526576?
This trial is sponsored by Antria, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02526576's enrollment target sits among peer trials
34 1539th of 2000 higher than 448 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia